| Thursday 29 January - Day one |
| 11.45am | Registration, lunch, exhibition and poster viewing |
| 12.30pm | Welcome and introduction
Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust, and Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery
|
12.50pm
| Session 1: Novel imaging in SRS
- Could rCBV Values Prior to SRS be Used to Predict Progression Status of Brain Metastases?
Heather Rowe, Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust
- Beyond Conventional MRI: Advanced Imaging in Post-SRS Treatment Response Assessment
Dr Markand Patel, Clinical Research Fellow, University of Birmingham
- Evaluating early changes in the post-radiosurgery vestibular schwannoma microenvironment: a multinuclear MRI study
Dr Daniel Lewis, NIHR Clinical Lecturer, Division of Cancer Sciences, University of Manchester
- Optimal imaging for planning AVMs
Dr George Tse, Consultant Interventional Neuroradiologist, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust
- Discussion
|
| 1.50pm | Session 2: Single session versus hypofractionation for benign targets
- Cyberknife radiosurgery and hypofractionated stereotactic radiotherapy for larger vestibular schwannomas
Dr Amy Irwin, Department of Oncology, Queen Elizabeth Hospital Birmingham - Single - vs multi-fraction radiosurgery for Benign Targets
Natasha Chaudary, Clinical Oncology Registrar, Royal Marsden Hospital Trust
- Outcomes using Cyberknife Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Meningiomas
Dr James Riley, Clinical Oncology Registrar, Queen Elizabeth Hospital Birmingham
- Hypofractionation for benign tumours
Dr Paul Sanghera, Consultant Oncologist, University Hospitals Birmingham
|
| 2.40pm | Session 3: Sponsored Presentations (I)
- Sponsored session – Novocure
- Sponsored session – Elekta
|
| 3.00pm | Refreshments, exhibition and poster viewing
|
| 3.30pm | Session 4: Use of PTVs and managing uncertainty in SRS
- Keynote: The Case for margins in SRS
Professor Marcel Van Herk, Chair in Radiotherapy Physics, The University of Manchester
- The case against margins in SRS
Ian Paddick, Consultant Physicist, Medical Physics Limited
- Discussion
|
| 4.10pm | Session 5: Approaches and outcomes from SRS for brain metastases: Case reports
- Multi-arc non-coplanar VMAT - can extracranial dose be reduced without compromising plan quality
Esmé Votta, Radiotherapy Physicist, Barts Health NHS Trust - Investigating the optimal prescription isodose for linac-based SRS
Dan Welsh, The Christie NHS Foundation Trust - One isocenter to treat them all: a 10 year retrospective study of SRS for Multiple Brain Metastases
Gabriella Pastore, Medical Physicist, Ecomedica-Ergéa Group - CyberKnife Stereotactic Radiosurgery for Brainstem Metastases
Mitchell Hickman, Consultant Radiographer – SRS, Queen Elizabeth Hospital Birmingham
|
| 4.55pm | Session 6: AVMs
- Stereotactic Radiosurgery for Persistent Paediatric AVMs: The Relevance of Previous Treatment Response on the Decision for Further Treatment, National Centre for Stereotactic Radiosurgery in Sheffield, UK
David Eagle, National Centre for Stereotactic Radiosurgery
- Commissioning of an Arteriovenous Malformation (AVM) Service at the Bristol GammaKnife Centre
Lucy Winch, Principal Clinical Scientist, Head of Dosimetry Development, Bristol Haematology and Oncology Centre
|
| 5.15pm | How
we would treat: Discussion on the treatment of interesting clinical cases -
benign
Chair: Dr Rovel Colaco, Consultant Clinical Oncologist, The Christie NHS Foundation Trust
Panel: Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery, Ian Paddick, Consultant Physicist, Medical Physics Limited, Dr Paul Sanghera, Consultant Oncologist, University Hospitals Birmingham, and Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust
|
| 6.00pm | Business
meeting
|
| 6.30pm | Close |
| 7.30pm | Meeting Dinner
Victoria and Albert Hotel
|
| Friday 30 January - Day two
|
8.30am
| Registration, refreshments, exhibition and poster viewing |
| 8.55am | Welcome and introduction
Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust, and Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery
|
| 9.00am | Session 7: Systemic therapies and patterns of care
- Sequencing radiosurgery with systemic therapy in melanoma brain metastases
Professor Mark Pinkham, Radiation Oncologist, Princess Alexandra Hospital and Icon Cancer Centre, Australia - Access to stereotactic radiosurgery centres across the United Kingdom – an investigation of travel time
Dr Stephen Robinson, Medical Doctoral Fellow and Clinical Oncology Registrar, University Hospitals Sussex NHS Foundation Trust, University of Sussex, Department of Biochemistry and Biomedicine - Radionecrosis in brain tumours: National insights on care provision and access to bevacizumab in the United Kingdom
Dr Sarah Kingdon, Fellow, Tessa Jowell Brain Cancer Mission
- Radiosurgery for Brain Metastases: From Few to Many — The New Normal?
Ana Luis, Physicist, Medical Physics Limited
|
| 9.55am | Session 8: Pituitary Adenomas
- Keynote: Endocrine outcomes after surgery – awaiting title
Professor Karim Meeran, Consultant Endocrinologist, Imperial College Healthcare NHS Trust
- Keynote: Endocrine outcomes after SRS
Professor
Jean Régis, Neurosurgery, Aix Marseille University, France
- Discussion
|
| 10.45am | Refreshments, exhibition and poster viewing
|
11.15am
| Session 9: Sponsored Presentations (II)
- Sponsored session – Brainlab
- Sponsored session – Accuray
- Sponsored session – ZAP Surgical
|
| 11.50am | Session 10: Vestibular Schwannoma
- Keynote: SRS for vestibular schwannoma: Large tumours, retreatment with SRS, what are our organs at risk?
Professor
Jean Régis, Neurosurgery, Aix Marseille University, France
- SRS
QA updates - Learning outcomes from the current national SRS QA Programme: Has
practice changed since initial commissioning?
Luke Gilling, Clinical Scientist, National Radiotherapy Trials Quality Assurance Group, Mount Vernon Cancer Centre
|
| 12.30pm | Lunch, exhibition and poster viewing
|
| 1.15pm | Session 11: SRS for Functional Disorders
- Keynote: SRS for movement disorders
Professor
Jean Régis, Neurosurgery, Aix Marseille University, France - Evaluation of Elements’ MRI distortion correction in radiosurgery planning
Dr Abdul Hussein Mroué, Lead SRS Physicist, GenesisCare - Initial experience of using Cyberknife to deliver prolonged fractionation
Mitchell Hickman, Consultant Radiographer – SRS, Queen Elizabeth Hospital Birmingham
|
| 2.00pm | Session 12: Treatment planning and other topics
- Planning a vestibular schwannoma with Gamma Knife – live demonstration
Ian Paddick, Consultant Physicist, Medical Physics Limited - How we do it: Planning a vestibular schwannoma with the Cyberknife
Dr Paul Sanghera, Consultant Oncologist, University Hospitals Birmingham, and Timothy Jackson, Queen Elizabeth Hospital Birmingham
- How we do it: Planning a vestibular schwannoma with a linac
Dr Abdul Hussein Mroué, Lead SRS Physicist, GenesisCare
- Discussion
|
| 2.50pm | Session 13: Quality of life and Patient-Reported Outcome Measures in SRS
- Capturing quality-of-life and experience pre-SRS in patients diagnosed with brain metastases
Kerlann Le Calvez, Research Associate, Imperial College Healthcare NHS Trust
- Outcomes for Patients with Frailty Receiving SRS for Brain Metastases
Catherine Fell, The Christie NHS Foundation Trust - Cognitive Decline after Brain Radiosurgery (CoDeB-Rad) at 3 months: Cognitive and Quality of Life (QoL) data
Anna Bangiri, Principal SRS Radiotherapy Physicist, PhD Fellow, University of Nottingham, Nottingham University Hospitals NHS Trust
- Hippocampal Dosimetry and Neurocognitive Function in Patients undergoing Stereotactic Radiosurgery
Dr Najmus Sahar Iqbal, Consultant in Clinical Oncology, Velindre University NHS Trust
|
| 3.30pm | Refreshments, exhibition
and poster viewing
|
| 3.50pm | What are the challenges and opportunities for equitable SRS access? Insights from the Tessa Jowell Brain Cancer Mission
Dr Nicky Huskens, CEO, Tessa Jowell Brain Cancer Mission
|
| 4.10pm | Update on DVLA driving restrictions post SRS
Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery
|
| 4.30pm | Closing remarks
Dr Matthew Williams, Consultant Clinical Oncologist, Imperial College Healthcare NHS Trust, and Julian Cahill, Consultant, The National Centre for Stereotactic Radiosurgery
|